Status:
COMPLETED
PTSD Mobile App for Cancer Survivors
Lead Sponsor:
Duke University
Conditions:
Posttraumatic Stress Disorder
Cancer
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of this study is to use a stepped-care approach in treating symptoms of posttraumatic stress disorder (PTSD). The information learned by doing this study may help us to develop some target...
Eligibility Criteria
Inclusion
- Completion of autologous or allogeneic HCT 1-5 years previously
- Partial or complete remission (NED), may be receiving chemoprevention
- Absence of severe psychological impairment (eg hospitalization for suicidality)
- Approved for contact by oncologist
- Able and willing to participate in a one-hour baseline interview
- No prior CBT for PTSD
- Owns a smart device with internet and email access
- Able to read and write English
- Significant PTSD symptoms as indicated by at least one of the following two criteria: probable cancer-related PTSD on the PCL5 by using the symptom cluster criteria; subthreshold or partial PTSD symptoms as determined by endorsement of reexperiencing cluster and less than or equal to 1 other symptom cluster
Exclusion
- If the participant does not fulfill the inclusion criteria
Key Trial Info
Start Date :
January 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 29 2025
Estimated Enrollment :
524 Patients enrolled
Trial Details
Trial ID
NCT04058795
Start Date
January 24 2021
End Date
May 29 2025
Last Update
July 30 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering
New York, New York, United States, 10065
2
Duke University
Durham, North Carolina, United States, 27710
3
Fred Hutchinson Cancer Center
Seattle, Washington, United States, 98109